Journals / Turkish Journal of Medical Sciences / 2012 / Cilt: 42 - Sayı: 3

A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele*

Kriptorşit, oligospermi ve varikoselli hastalarda anti-müllerian hormon (AMH) ve farklı biyokimyasal parametrelerin karşılaştırılması

Pages
411–415
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: New studies with larger number of participants are needed in order to determinate AMH levels in patients with varicocele, cryptorchidism, or varicocele for diagnostic criteria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To investigate the serum AMH and various biochemical parameter levels in patients with cryptorchidism, oligospermia, or varicocele.
📊
Key Findings & Data:Materials and methods: This study included 100 participants, divided into 5 groups: cryptorchidism (n = 20), varicocele (n = 20), oligospermia (n = 20), and 2 control groups [control 1, 8-12 years old (n = 20) and control 2, 18-24 years old (n= 20)].
💡
Conclusion & Impact:Conclusion: New studies with larger number of participants are needed in order to determinate AMH levels in patients with varicocele, cryptorchidism, or varicocele for diagnostic criteria.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anti-Müllerian hormon · varikosel · infertilite

Abstract

To investigate the serum AMH and various biochemical parameter levels in patients with cryptorchidism, oligospermia, or varicocele. Materials and methods: This study included 100 participants, divided into 5 groups: cryptorchidism (n = 20), varicocele (n = 20), oligospermia (n = 20), and 2 control groups [control 1, 8-12 years old (n = 20) and control 2, 18-24 years old (n= 20)]. Using the blood samples drawn from both patient and control groups, AMH, testosterone, FSH, LH, and prolactin parameters were investigated. Results: AMH values measured were found to be 73.04 ± 44.5 ng/mL and 84.81 ± 59.1 ng/mL in 20 children with cryptorchidism and 20 healthy children (both groups aged between 8 and 12 years), respectively (P = 0.56). In the present study, AMH values were found to be 5.19 ± 4.9 ng/mL and 7.66 ± 5.6 ng/mL in 20 patients with oligospermia and 20 healthy individuals (both groups aged between 18 and 24 years), respectively (P = 0.10). AMH values in 20 patients with varicocele and 20 healthy controls aged between 18 and 24 years were determined to be 7.15 ± 5.8 ng/mL and 7.66 ± 5.6 ng/mL, respectively (P = 0.82). No significant P values were determined, but the decrease in values was remarkable. Conclusion: New studies with larger number of participants are needed in order to determinate AMH levels in patients with varicocele, cryptorchidism, or varicocele for diagnostic criteria.

Özet

Amaç: Kriptorşit, oligospermi ve varikosel tanılı hastalarda AMH ve farklı biyokimyasal parametrelerin kıyaslanmasıyoluyla değişimin saptanması.Yöntem ve gereç: Çalışmaya 18-24 yaş arası varikosel (n = 20), oligospermi (n = 20) ile 8-12 yaş arası kriptorşit (n = 20)hasta grupları; 8-12 yaş arası (n = 20) ve 18-24 yaş arası (n = 20) sağlıklı bireyler kontrol gruplar olarak alındı. Hasta vekontrol gruplarından kan örnekleri alınarak AMH, testosteron, FSH, LH, ve prolaktin parametreleri çalışıldı.Bulgular:Çalışmada pubertal dönemde (8-12 yaş arası) 20 kriptorşitli çocuk ile 20 normal çocuk AMH değerleri sırasıyla 73,04± 44,5 ng/mL ve 84,81 ± 59,1 ng/mL olarak bulunurken (P = 0,56) postpubertal dönemde (18-24 yaşarası) 20 oligospermilihasta ile 20 normal birey AMH değerleri sırasıyla 5,19 ± 4,9 ng/mL ve 7,66 ± 5,6 ng/mL (P = 0,10) ve 20 varikoselli hasta ile 20normal birey AMH değerleri ise sırasıyla 7,15 ± 5,8 ng/mL ve 7,66 ± 5,6 ng/mL (P = 0,82) olarak saptandı.Sonuç: AMH düzeylerinin belirlenmesine yönelik daha geniş katılımcı ile yapılacak yeni çalışmalarla varikosel, oligospermive kriptorşidik vakalarda serum AMH ölçümünün tanı kriteri olabileceği düşünülmektedir.

🔖

Cite This Article

TİFTİK, A. M., SARIYILDIZ, L., AKDAĞ, T. (2022). A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele*. Turkish Journal of Medical Sciences, Cilt: 42 - Sayı: 3, 411–415. https://ajindex.com/articles/611189

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Massague J. Th e transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641.
  2. Rajpert-De ME, Jorgensen N, Graem N, Müller J, Cate RL, Skakkebaek NE. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with diff erentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999; 84: 3836-3844. Rodolfo R. Anti-Müllerian hormone in disorders of sex determination and diff erentiation. Arq Bras Endocrinol Metab 2005; 49: 26-36.
  3. AH Lane, PK Donahoe. New insights into Mullerian inhibiting substance and its mechanism of action. J Endocrinol 1998; 158: 1-6.
  4. Kumar A, Karla B, Patel A, McDavid L, Roudebush WE. Development of a second generation Anti-Müllerian hormone (AMH) ELISA. J Immunol Methods 2010; 362: 51-59.
  5. Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfi eld M, Visser JA et al. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol 2005; 63: 267-273. 7. Grinspon RP, Rey RA. Anti-müllerian hormone and sertoli cell function in pediatric male hypogonadism. Horm Res Paediatr 2010; 73: 81-92.
  6. Josso N, Racine C, di Clemente N, Rey R, Xavier F. Th e role of anti-Müllerian hormone in gonadal development. Mol Cell Endocrinol 1998; 145: 3-7.
  7. Griffi n JE, Ojeda S. Textbook of Endocrinology. New York: Oxford University Press; 1988. Goodman MH. Basic Medical Endocrinology. 3rd ed. USA: Elsevier Science; 1988.
  8. Serge N, Luis FP.Hormones in male sexual development. Genes Dev 2000; 14: 3075-3086.
  9. Aksglaede L, Sİrensen K, Boas M, Mouritsen A, Hagen C, Jensen R et al. Changes in Anti-Müllerian Hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol & Metabol 2010; 95: 5357-5364.
  10. Josso N, Boussin L, Knebelmann B, Nihoul-Fékété C, Picard JY. Anti-Müllerian hormone and intersex states. Trends Endocrinol Metabol 1991; 2: 227-233.
  11. Josso N, Racine C, di Clemente N, Rey R, Xavie r F. Th e role of anti-Müllerian hormone in gonadal development. Mol Cell Endocrinol 1998; 145: 1-2. World Health Organization. Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 4th ed. New York: Cambridge University Press; 1999.
  12. Wackerly D, Mendenhall W, Scheaff er RL. Mathematical Statistics with Applications. USA: Th omson Learn; 2002.
  13. Lee MM, Misra M, Donahoe PK, MacLaughlin DT. MIS/